SL Science Holding SLBT
NASDAQ SLBT
$1.27 +0.06 (+5.00%)
As of: Oct 29, 2026 · 11:12 AM EDT

SL Science Holding (SLBT) Net Income (2025 - 2026)

Updated

SL Science Holding (SLBT) posted Net Income of -$2.13 million for Q2 2026, compared with -$2.07 million a year earlier.

Analysis

SL Science Holding (SLBT) Net Income (2025 - 2026) Analysis & Trends

For FY2025, SL Science Holding's Net Income came in at -$3.82 million.

  • In prior years, SL Science Holding's Net Income was -$1.19 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,218.53 Bn 1,187.11 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 662.89 Bn 582.75 Bn 17.30 Bn 210.00 Mn
3 AbbVie 512.78 Bn 485.89 Bn 12.70 Bn 3.62 Bn
4 Merck 364.74 Bn 319.12 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 310.96 Bn 284.20 Bn - -
6 Astrazeneca 270.15 Bn 243.84 Bn 12.86 Bn 2.51 Bn
7 Amgen 248.59 Bn 203.99 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 201.20 Bn 175.40 Bn 6.22 Bn -10.50 Bn
9 Pfizer 169.69 Bn 116.33 Bn 10.94 Bn -248.00 Mn
10 SL Science Holding 2.77 Bn 2.76 Bn - -2.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.13 Mn
Mar 31, 2026 -29,122.00
Jun 30, 2025 -2.07 Mn
API Access

SL Science Holding Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=SLBT&period=max&api_key=YOUR_API_KEY